Drug Discovery & Development

Strategies & Technologies Driving Drug Discovery to Market

Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Battelle Ventures Spins Out Life Science Company from MIT

February 26, 2009 5:00 am | News | Comments

Battelle Ventures, LP, has spun out Hepregen Corporation from the Massachusetts Institute of Technology.

TOPICS:

Former FDA Commissioner Joins Greenleaf Health

February 26, 2009 4:43 am | News | Comments

Greenleaf Health LLC announced that Andrew C. von Eschenbach, MD, who recently stepped down as Commissioner of the Food and Drug Administration (FDA), has joined the firm as Senior Advisor.

TOPICS:

Use of Potassium Iodide Encouraged In Prenatal Vitamins

February 26, 2009 4:17 am | News | Comments

Researchers from Boston University School of Medicine (BUSM) are encouraging prenatal vitamin manufacturers to use only potassium iodide and not other sources of iodine in their products.

TOPICS:
Advertisement

Millipore Announces Technology Acquisition

February 26, 2009 3:46 am | News | Comments

Millipore Corporation announced that it has purchased the assets associated with Epitome Biosystems’ EpiTag technology.

TOPICS:

Biomarker Predicts Disease Recurrence in Colorectal Cancer

February 26, 2009 3:29 am | News | Comments

Findings by researchers at Thomas Jefferson University show that the presence of a biomarker in regional lymph nodes is an independent predictor of disease recurrence in patients with colorectal cancer.

TOPICS:

ICG Commerce Selected by Teva Pharmaceuticals

February 25, 2009 11:58 am | News | Comments

ICG Commerce has signed an agreement with Teva Pharmaceuticals to manage part of their indirect spend.

TOPICS:

Trialytics Delivers Expanded Protocols for Clinical Trial Design

February 25, 2009 11:51 am | News | Comments

Trialytics announced an expansion of its core services to include increased clinical trial data resources, multiple protocols, and a comprehensive physician lead qualification program.

TOPICS:

Almac Clinical Technologies Expands Yardley, PA Headquarters

February 25, 2009 11:42 am | News | Comments

Almac Clinical Technologies announced that it has added 6,000 square feet of space at its Yardley, Pennsylvania USA headquarters.

TOPICS:
Advertisement

PPD Enters Into Collaboration with Merck

February 25, 2009 11:35 am | News | Comments

PPD, Inc. announced it has entered into a strategic collaboration with Merck.

TOPICS:

Protein Isolation Kit

February 25, 2009 11:21 am | Product Releases | Comments

GE Healthcare introduced the illustra triplePrep, a kit for rapid, simultaneous isolation of genomic DNA, RNA, and total denatured protein from a single undivided sample.

TOPICS:

MDRNA Announces Licensing Agreement With Roche

February 25, 2009 11:12 am | News | Comments

MDRNA, Inc. announced that it has entered into an agreement with Roche.

TOPICS:

New Piece Found to Alzheimer's Puzzle

February 25, 2009 10:41 am | News | Comments

Yale researchers have filled in a missing gap on the molecular road map of Alzheimer's disease.

TOPICS:

Compounds that Trigger Beta Cell Replication Identified

February 25, 2009 10:25 am | News | Comments

Researchers at the Genomics Institute of the Novartis Research Foundation (GNF) have identified a set of compounds that can trigger the proliferation of insulin-producing cells in the pancreas, using sophisticated high-throughput screening techniques.

TOPICS:

Elan Cuts 14% of Jobs in Ireland, US

February 25, 2009 7:13 am | by Shawn Pogatchnik, Associated Press Writer | News | Comments

Elan Corp. PLC announced it will cut 230 jobs in Ireland and the United States, representing 14 percent of its work force, as part of its long-running struggle to return to profitability.

TOPICS:

Potential Colon Cancer Biomarker Discovered

February 25, 2009 7:10 am | News | Comments

Researchers at the University of Cincinnati have discovered genetic variations that may prove to be key predictors of risk for colon cancer and indicators of the disease’s progression.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading